These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35935217)

  • 1. Impact of a phage cocktail targeting
    Buttimer C; Sutton T; Colom J; Murray E; Bettio PH; Smith L; Bolocan AS; Shkoporov A; Oka A; Liu B; Herzog JW; Sartor RB; Draper LA; Ross RP; Hill C
    Front Microbiol; 2022; 13():936083. PubMed ID: 35935217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex Bacterial Consortia Reprogram the Colitogenic Activity of
    Lengfelder I; Sava IG; Hansen JJ; Kleigrewe K; Herzog J; Neuhaus K; Hofmann T; Sartor RB; Haller D
    Front Immunol; 2019; 10():1420. PubMed ID: 31281321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of an AIEC-targeted Bacteriophage Cocktail in a Mice Colitis Model.
    Titécat M; Rousseaux C; Dubuquoy C; Foligné B; Rahmouni O; Mahieux S; Desreumaux P; Woolston J; Sulakvelidze A; Wannerberger K; Neut C
    J Crohns Colitis; 2022 Nov; 16(10):1617-1627. PubMed ID: 35997152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage Cocktail Targeting STEC O157:H7 Has Comparable Efficacy and Superior Recovery Compared with Enrofloxacin in an Enteric Murine Model.
    Wang Y; Subedi D; Li J; Wu J; Ren J; Xue F; Dai J; Barr JJ; Tang F
    Microbiol Spectr; 2022 Jun; 10(3):e0023222. PubMed ID: 35536028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota.
    Cieplak T; Soffer N; Sulakvelidze A; Nielsen DS
    Gut Microbes; 2018; 9(5):391-399. PubMed ID: 29517960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phages in a thermoreversible sustained-release formulation targeting E. faecalis in vitro and in vivo.
    Shlezinger M; Friedman M; Houri-Haddad Y; Hazan R; Beyth N
    PLoS One; 2019; 14(7):e0219599. PubMed ID: 31291645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Antimicrobial-Resistant
    Kim J; Park H; Ryu S; Jeon B
    Front Microbiol; 2021; 12():699630. PubMed ID: 34512575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of bacterial antigen-specific colitis by a simplified human microbiota consortium in gnotobiotic interleukin-10-/- mice.
    Eun CS; Mishima Y; Wohlgemuth S; Liu B; Bower M; Carroll IM; Sartor RB
    Infect Immun; 2014 Jun; 82(6):2239-46. PubMed ID: 24643531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Bacteriophage EF-P29 Efficiently Protects against Lethal Vancomycin-Resistant
    Cheng M; Liang J; Zhang Y; Hu L; Gong P; Cai R; Zhang L; Zhang H; Ge J; Ji Y; Guo Z; Feng X; Sun C; Yang Y; Lei L; Han W; Gu J
    Front Microbiol; 2017; 8():837. PubMed ID: 28536572
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficiency of Single Phage Suspensions and Phage Cocktail in the Inactivation of
    Costa P; Pereira C; Gomes ATPC; Almeida A
    Microorganisms; 2019 Mar; 7(4):. PubMed ID: 30935094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of a novel bacteriophage cocktail as a preventative for bovine coliform mastitis.
    Porter J; Anderson J; Carter L; Donjacour E; Paros M
    J Dairy Sci; 2016 Mar; 99(3):2053-2062. PubMed ID: 26774718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Response of an Oral
    Mendes BG; Duan Y; Schnabl B
    Viruses; 2022 Feb; 14(3):. PubMed ID: 35336897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage Cocktails Constrain the Growth of
    Wandro S; Ghatbale P; Attai H; Hendrickson C; Samillano C; Suh J; Dunham SJB; Pride DT; Whiteson K
    mSystems; 2022 Aug; 7(4):e0001922. PubMed ID: 35762793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vivo efficacy of two administration routes of a phage cocktail to reduce numbers of Campylobacter coli and Campylobacter jejuni in chickens.
    Carvalho CM; Gannon BW; Halfhide DE; Santos SB; Hayes CM; Roe JM; Azeredo J
    BMC Microbiol; 2010 Sep; 10():232. PubMed ID: 20809975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defeating Antibiotic- and Phage-Resistant
    Khalifa L; Gelman D; Shlezinger M; Dessal AL; Coppenhagen-Glazer S; Beyth N; Hazan R
    Front Microbiol; 2018; 9():326. PubMed ID: 29541067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of phage EF-N13 as an alternative treatment strategy for mastitis infections caused by multidrug-resistant Enterococcus faecalis.
    Ji Y; Zhao Z; Jiang Q; Loor JJ; Song L; Ou H; Liu M; Sun C; Feng X; Lei L; Han W; Li X; Gu J
    J Dairy Sci; 2023 Dec; 106(12):9174-9185. PubMed ID: 37641240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Basis for Lytic Bacteriophage Resistance in Enterococci.
    Duerkop BA; Huo W; Bhardwaj P; Palmer KL; Hooper LV
    mBio; 2016 Aug; 7(4):. PubMed ID: 27578757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli.
    Malik S; Nehra K; Rana JS
    Virus Res; 2021 Sep; 302():198496. PubMed ID: 34182014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phage biocontrol of enteropathogenic and Shiga toxin-producing Escherichia coli during milk fermentation.
    Tomat D; Mercanti D; Balagué C; Quiberoni A
    Lett Appl Microbiol; 2013 Jul; 57(1):3-10. PubMed ID: 23551112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy.
    Chibani-Chennoufi S; Sidoti J; Bruttin A; Kutter E; Sarker S; Brüssow H
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2558-69. PubMed ID: 15215109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.